Bergen Brunswig Reports Record Annual Earnings and Revenue

Bergen Brunswig Corp. posted record earnings and revenue for the fiscal year ended Sept. 30, the distributor of pharmaceuticals and medical surgical supplies said Thursday.

Net income rose 15.6% to $73.9 million, or $1.83 per share, from $63.9 million, or $1.61 per share, for the previous year. Revenue climbed nearly 18%, outpacing the company’s top two competitors, said Robert E. Martini, chairman and chief executive. Revenue totaled $9.9 billion, up from $8.4 billion.

For the fourth quarter, the company earned $18.3 million, or 45 cents a share, a 16.6% increase over the $15.7 million, or 39 cents a share, earned a year ago. Revenue climbed more than 18% to $2.6 billion from $2.2 billion.